Table 2

Univariable and multivariable associations of baseline characteristics with infarct in new territory (INT) on logistic regression models

Univariable analysesUnivariable analysesMultivariable analyses
OR (95% CI)P valueOR (95% CI)P value
Age1.01 (0.99 to 1.03)0.213
African-American race1.48 (0.81 to 2.72)0.199
Male sex0.64 (0.36 to 1.15)0.136
Hypertension2.08 (0.90 to 4.77)0.0851.57 (0.56 to 4.37)0.392
Diabetes mellitus0.89 (0.47 to 1.67)0.719
Hypercholesterolemia1.30 (0.73 to 2.31)0.369
Congestive heart failure1.30 (0.73 to 2.32)0.372
Current smoking0.66 (0.33 to 1.31)0.241
History of stroke1.43 (0.72 to 2.82)0.306
History of CAD1.56 (0.84 to 2.88)0.158
Atrial fibrillation0.78 (0.38 to 1.58)0.488
IV tPA0.48 (0.26 to 0.85)0.0120.75 (0.32 to 1.76)0.506
Good collaterals0.56 (0.30 to 1.06)0.0750.68 (0.30 to 1.53)0.356
Pretreatment with antiplatelets1.69 (0.94 to 3.05)0.0791.26 (0.57 to 2.78)0.560
Pretreatment with oral anticoagulant1.52 (0.72 to 3.23)0.275
Pretreatment with statin0.81 (0.44 to 1.52)0.518
Baseline NIHSS score1.01 (0.97 to 1.05)0.585
Admission SBP1.01 (1.00 to 1.01)0.159
Admission DBP1.00 (0.99 to 1.01)0.764
Baseline ASPECTS score0.90 (0.73 to 1.10)0.298
OTGPT1.01 (1.00 to 1.03)0.0391.00 (0.99 to 1.01)0.211
Admission serum glucose1.00 (0.99 to 1.01)0.188
Occlusion site in posterior circulation0.28 (0.14 to 0.55)<0.0013.33 (1.43 to 7.69)0.005
Proximal occlusion in anterior circulation0.64 (0.26 to 1.60)0.346
Number of passes during MT1.22 (0.89 to 1.68)0.204
Cardio-embolic cause of stroke0.82 (0.45 to 1.50)0.526
General anesthesia1.07 (0.55 to 2.06)0.831
Balloon guide use during MT1.14 (0.42 to 3.09)0.792
  • *Proximal, M1 and/or ICA (extra- or intracranial).

  • ASPECTS, Alberta Stroke Program Early CT Score; CAD, coronary artery disease; DBP, diastolic blood pressure; IV tPA, intravenous tissue plasminogen activator; MT, mechanical thrombectomy; NIHSS, National Institutes of Health Stroke Scale; OTGPT, onset-to-groin puncture time; SBP, systolic blood pressure.